These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 29702992)
21. History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea. Bae CW; Kim CY; Chung SH; Choi YS J Korean Med Sci; 2019 Jul; 34(25):e175. PubMed ID: 31243934 [TBL] [Abstract][Full Text] [Related]
22. Surfactant therapy failure identifies infants at risk for pulmonary mortality. Hamvas A; Devine T; Cole FS Am J Dis Child; 1993 Jun; 147(6):665-8. PubMed ID: 8506837 [TBL] [Abstract][Full Text] [Related]
23. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants? Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717 [TBL] [Abstract][Full Text] [Related]
24. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial]. Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406 [TBL] [Abstract][Full Text] [Related]
25. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants. Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674 [TBL] [Abstract][Full Text] [Related]
26. Surfactant replacement in preterm infants with respiratory distress syndrome. Dani C Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871 [TBL] [Abstract][Full Text] [Related]
27. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era. Wright K J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014 [TBL] [Abstract][Full Text] [Related]
28. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
29. Mortality of neonatal respiratory failure from Chinese northwest NICU network. Zhang L; Qiu Y; Yi B; Ni L; Zhang L; Taxi P; Li H; Zhang Q; Wang W; Liu Z; Li L; Zhao L; Wang H; Sun B; J Matern Fetal Neonatal Med; 2017 Sep; 30(17):2105-2111. PubMed ID: 27651118 [TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical efficacy of Newfactan versus Surfacten for the treatment of respiratory distress syndrome in the newborn infants. Choi CW; Hwang JH; Yoo EJ; Kim KA; Koh SY; Lee YK; Shim JW; Lee EK; Chang W; Kim SS; Chang YS; Park WS; Shin SM J Korean Med Sci; 2005 Aug; 20(4):591-7. PubMed ID: 16100449 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the immediate response to surfactant. Kuint J; Reichman B; Neumann L; Shinwell ES Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of antenatal corticosteroids according to maternal and perinatal factors: a retrospective cohort study. Claire L; Vieux R Am J Perinatol; 2015 Sep; 32(11):1070-7. PubMed ID: 25825960 [TBL] [Abstract][Full Text] [Related]
33. [Combined use of pulmonary surfactants with continuous distending pressure is useful in the treatment of respiratory distress syndrome in very low birth weight infants]. Liu CJ; Yang ZY; Chen Z; Shao XH Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):451-4. PubMed ID: 18706159 [TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery. Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901 [TBL] [Abstract][Full Text] [Related]
35. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao. Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907 [TBL] [Abstract][Full Text] [Related]
36. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Reynolds MS; Wallander KA Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398 [TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380 [TBL] [Abstract][Full Text] [Related]
38. Surfactant therapy in full-term neonates with severe respiratory failure. Khammash H; Perlman M; Wojtulewicz J; Dunn M Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059 [TBL] [Abstract][Full Text] [Related]
39. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue. Bevilacqua G; Parmigiani S; J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975 [TBL] [Abstract][Full Text] [Related]
40. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Dunn MS; Shennan AT; Zayack D; Possmayer F Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]